FDA Inspection
ARL Biopharma, Inc.ARL Biopharma, Inc. – FDA Inspection, Sep 20, 2019
Record Details
This FDA Inspection record concerns ARL Biopharma, Inc., with an inspection on September 20, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 00b13fc7-baf0-4864-922b-b9359c7c19bc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102393
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of ARL Biopharma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2026 | Not classified | Dallas District Office | |
| March 25, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ARL Biopharma, Inc.
- FDA Inspection 1322550 - 2026-05-22
- FDA Inspection 965921 - 2016-03-25
- FDA Inspection 806356 - 2012-11-08
- FDA Inspection 701726 - 2010-11-19
- FDA Inspection 651237 - 2010-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.